Order Article Reprints

Aroua LM, Alosaimi AH, Alminderej FM, Messaoudi S, Mohammed HA, Almahmoud SA, Chigurupati S, Albadri AEAE, Mekni NH. Synthesis, Molecular Docking, and Bioactivity Study of Novel Hybrid Benzimidazole Urea Derivatives: A Promising α-Amylase and α-Glucosidase Inhibitor Candidate with Antioxidant Activity. Pharmaceutics. 2023; 15(2):457. https://doi.org/10.3390/pharmaceutics15020457

Aroua, Lotfi M., Abdulelah H. Alosaimi, Fahad M. Alminderej, Sabri Messaoudi, Hamdoon A. Mohammed, Suliman A. Almahmoud, Sridevi Chigurupati, Abuzar E. A. E. Albadri, and Nejib H. Mekni. 2023. "Synthesis, Molecular Docking, and Bioactivity Study of Novel Hybrid Benzimidazole Urea Derivatives: A Promising α-Amylase and α-Glucosidase Inhibitor Candidate with Antioxidant Activity" Pharmaceutics 15, no. 2: 457. https://doi.org/10.3390/pharmaceutics15020457

Aroua, L. M., Alosaimi, A. H., Alminderej, F. M., Messaoudi, S., Mohammed, H. A., Almahmoud, S. A., Chigurupati, S., Albadri, A. E. A. E., & Mekni, N. H. (2023). Synthesis, Molecular Docking, and Bioactivity Study of Novel Hybrid Benzimidazole Urea Derivatives: A Promising α-Amylase and α-Glucosidase Inhibitor Candidate with Antioxidant Activity. Pharmaceutics, 15(2), 457. https://doi.org/10.3390/pharmaceutics15020457